Tech Company M&A Transactions
Plexxikon Acquisition
Headquartered in Berkeley, Plexxikon was acquired by Daiichi Sankyo. Financial terms set the valuation at $935 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/28/2011
Transaction Type
M&A
Amount
$935,000,000
M&A Terms
The purchase price for Plexxikon is $805 million up-front. Near-term milestone payments associated with the approval of PLX4032 could total an additional $130 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
91 Bolivar Drive
Berkeley, CA 94710
USA
Berkeley, CA 94710
USA
Phone
Website
Email Address
Overview
Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas, including metabolic disease, oncology, inflammation, CNS and cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Hirth
Chief Medical Officer
Keith Nolop
President
Kathleen Glaub
Vice President
Gideon Bollag
Vice President
Prabha Ibrahim
Vice President
Gary Visor
Browse more venture capital transactions:
Prev: 2/28/2011: The Climate Corporation venture capital transaction
Next: 2/28/2011: DynamicOps venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs